Voya Financial (VOYA) Q3 Earnings and Revenues Top Estimates

Omega Healthcare Investors (OHI) reported $144.85 million in revenue for the quarter ended December 2022, representing a year-over-year decline of 42.1%. EPS of $0.73 for the same period compares to $0.14 a year ago.

The reported revenue represents a surprise of -6.11% over the Zacks Consensus Estimate of $154.28 million. With the consensus EPS estimate being $0.73, the company has not delivered EPS surprise.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company’s financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock’s price performance.

Here is how Omega Healthcare Investors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Rental income: $110.15 million versus the four-analyst average estimate of $144.81 million. The reported number represents a year-over-year change of -48.6%.
  • Income from direct financing leases: $0.26 million compared to the $0.24 million average estimate based on three analysts. The reported number represents a change of -0.8% year over year.
  • Real estate tax and ground lease income: $4.16 million versus $4.41 million estimated by three analysts on average.
  • Diluted- Net income (loss): $0.19 versus $0.25 estimated by four analysts on average.

View all Key Company Metrics for Omega Healthcare Investors here>>>

Shares of Omega Healthcare Investors have returned +3.9% over the past month versus the Zacks S&P 500 composite’s +7.4% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.

Just Released: Zacks Top 10 Stocks for 2023

In addition to the investment ideas discussed above, would you like to know about our 10 top picks for 2023?

From inception in 2012 through November, the Zacks Top 10 Stocks portfolio has tripled the market, gaining an impressive +884.5% versus the S&P 500’s +287.4%. Our Director of Research has now combed through 4,000 companies covered by the Zacks Rank and handpicked the best 10 tickers to buy and hold in 2023. Don’t miss your chance to still be among the first to get in on these just-released stocks.

See New Top 10 Stocks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Omega Healthcare Investors, Inc. (OHI) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Image and article originally from www.nasdaq.com. Read the original article here.

By Zacks